ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.799,09
-1,60%
S&P 500
5.954,50
1,59%
US Dollar vs BRL
5,8854
-0,01%
Bitcoin
94.097,55
9,39%
Brent Oil
73,045
0,00%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Faron Pharmaceuticals Oy (FARN)

  7. Faron Pharmaceuticals Oy (FARN) Notícias

FARN

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:FARN
DataHoraFonteTítuloCódigoCompanhia
28/02/202509:00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Annual General MeetingLSE:FARNFaron Pharmaceuticals Oy
27/02/202504:30RNS Regulatory NewsFaron Pharmaceuticals Oy Positive EMA Opinion on Orphan Drug DesignationLSE:FARNFaron Pharmaceuticals Oy
27/02/202504:15RNS Regulatory NewsFaron Pharmaceuticals Oy Annual Report 2024 publishedLSE:FARNFaron Pharmaceuticals Oy
27/02/202504:00RNS Regulatory NewsFaron Pharmaceuticals Oy Financial Statement 1 January to 31 December 2024LSE:FARNFaron Pharmaceuticals Oy
19/02/202507:00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Financial Statement and Annual ReportLSE:FARNFaron Pharmaceuticals Oy
14/02/202509:00RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
11/02/202504:30RNS Regulatory NewsFaron Pharmaceuticals Oy Change of BrokerLSE:FARNFaron Pharmaceuticals Oy
06/02/202508:41Alliance NewsAlliance NewsFaron Pharmaceuticals raises EUR12 million from oversubscribed placingLSE:FARNFaron Pharmaceuticals Oy
06/02/202504:00RNS Regulatory NewsFaron Pharmaceuticals Oy Results of Oversubscribed PlacingLSE:FARNFaron Pharmaceuticals Oy
05/02/202513:30RNS Regulatory NewsFaron Pharmaceuticals Oy Proposed Issue and PlacingLSE:FARNFaron Pharmaceuticals Oy
31/01/202504:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Final Patient Identified for BEXMAB Phase II StudyLSE:FARNFaron Pharmaceuticals Oy
13/12/202404:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron’s Financial Calendar for 2025LSE:FARNFaron Pharmaceuticals Oy
10/12/202411:31Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals shares up as presents data on BexmabLSE:FARNFaron Pharmaceuticals Oy
10/12/202404:47PR Newswire (US)Faron presents BEXMAB data at ASH Annual MeetingLSE:FARNFaron Pharmaceuticals Oy
10/12/202404:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron presents BEXMAB data at ASH Annual MeetingLSE:FARNFaron Pharmaceuticals Oy
02/12/202405:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Interactions with UK Regulatory AuthoritiesLSE:FARNFaron Pharmaceuticals Oy
27/11/202408:29Alliance NewsAlliance NewsFaron announces promising findings from blood cancer drug trialLSE:FARNFaron Pharmaceuticals Oy
27/11/202404:00RNS Regulatory NewsFaron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB TrialLSE:FARNFaron Pharmaceuticals Oy
11/11/202404:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Targeting Soluble Clever-1 for Autoimmune DiseasesLSE:FARNFaron Pharmaceuticals Oy
05/11/202404:00RNS Regulatory NewsFaron Pharmaceuticals Oy Shareholders’ Nomination BoardLSE:FARNFaron Pharmaceuticals Oy
22/10/202403:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron’s Capital Markets Day 2024LSE:FARNFaron Pharmaceuticals Oy
07/10/202403:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron announces Capital Markets DayLSE:FARNFaron Pharmaceuticals Oy
30/08/202403:00RNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
27/08/202407:08Alliance NewsAlliance NewsFaron Pharma shares surge as US FDA grants fast track designationLSE:FARNFaron Pharmaceuticals Oy
27/08/202403:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron 2024 Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
27/08/202403:00RNS Regulatory NewsFaron Pharmaceuticals Oy FDA Grants Fast Track Designation for BexmarilimabLSE:FARNFaron Pharmaceuticals Oy
20/08/202403:00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
13/08/202409:23Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals joins US grant for battlefield woundsLSE:FARNFaron Pharmaceuticals Oy
13/08/202403:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Traumakine Research Collaboration and DoD GrantLSE:FARNFaron Pharmaceuticals Oy
12/08/202408:01Alliance NewsAlliance NewsEXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRxLSE:FARNFaron Pharmaceuticals Oy
 Apresentando as notícias mais relevantes sobre:LSE:FARN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
FICT3
Fictor Alimentos ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
TECN3
TECHNOS ON
BOV
PDGR3
PDG REALT ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios